A Prospective, Randomized Controlled Study of the Probiotics as Adjuvant Treatment for Bacterial Vaginosis
Recruiting now · Phase 4
Conditions studied: Bacterial Vaginosis
In brief
The investigators are trying to determine if oral Probiotics(Umeta-mimi,30 days) with Metronidazole vaginal suppositories (7 days) is better than using Metronidazole vaginal suppositories(7 days) only in preventing the recurrence of bacterial vaginosis
Key facts
- Study ID
- NCT04771728
- Run by
- Peking University Shenzhen Hospital
- People needed
- 140
- Starts
- 2020-02-01
- Expected to finish
- 2026-12-01
- Last updated by the study team
- 2025-06-12
Who can join
Age: 18 and older, up to 55. Sex: female. Healthy volunteers: accepted.
You may qualify if…
- Aged 18 to 55 years old, with history of sexual activity,
- Amsel criterion for diagnosing BV
- Sign informed consent
You may not qualify if…
- History of systemic organic diseases or psychiatric diseases
- Planning for or during pregnancy, lactation, menstruation
- within 5 days of onset of the disease, any antibiotics has been used
- Long-term use of contraceptives or immunosuppressant
- Anaphylactic constitution or allergic to known ingredients of research drugs
- No same fixed partner (RSP) before and after treatment
Where it is running
- Peking University Shenzhen Hosptal — Shenzhen, Guangdong, China (enrolling)
Full record on ClinicalTrials.gov
Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.